Skip to main content
OpenTrials

Clinical trial condition

High Grade Glioma

Explore clinical trials studying High Grade Glioma. Study availability and eligibility vary by location and protocol.

69 public trials 33 recruiting studies
Refine in advanced search Browse all conditions

High Grade Glioma trial results

Recruiting

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

NCT04485559

Conditions
Glioma, High Grade Glioma, Low-grade Glioma, +8 more
Locations
  • University of Alabama at Birmingham, Children's of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California, San Diego Rady Children's Hospital San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 17 locations
View Trial Details
Recruiting

Study of Olutasidenib and Temozolomide in HGG

NCT06161974

Conditions
Astrocytoma, Astrocytoma, Grade III, Astrocytoma, Grade IV, +36 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University of Miami Hospital and Clinics Miami, Florida, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View all 20 locations
View Trial Details
Recruiting

Targeted Pediatric High-Grade Glioma Therapy

NCT05839379

Conditions
Anaplastic Astrocytoma, Astrocytoma, Brain Diseases, +24 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 21 locations
View Trial Details
Recruiting

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

NCT05843253

Conditions
Anaplastic Astrocytoma, Astrocytoma, Brain Diseases, +25 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 20 locations
View Trial Details
Recruiting

Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors

NCT06528691

Conditions
CNS Tumor, Central Nervous System Neoplasms, Glioma, +11 more
Locations
  • St. Jude Children's Research Hospital Memphis, Tennessee, United States
  • Hospital de Câncer de Barretos Barretos, São Paulo, Brazil
  • GRAACC Hospital (Grupo de Apoio ao Adolescente e à Criança com Câncer) São Paulo, Brazil
  • Hospital Santa Marcelina São Paulo, Brazil
View Trial Details
Recruiting

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

NCT05096481

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +19 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Nicklaus Children's Hospital Miami, Florida, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View all 13 locations
View Trial Details

Related conditions